• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在北塞浦路斯生活的尼日利亚和津巴布韦人群中 CCR5-Δ32 基因变异频率。

CCR5-Δ32 gene variant frequency in the Nigerian and Zimbabwean populations living in North Cyprus.

机构信息

Near East University, Faculty of Medicine, Department of Medical Biology, Nicosia, 99138, Cyprus.

Near East University, Faculty of Medicine, Department of Medical Genetics, Nicosia, 99138, Cyprus.

出版信息

Afr Health Sci. 2022 Mar;22(1):361-366. doi: 10.4314/ahs.v22i1.44.

DOI:10.4314/ahs.v22i1.44
PMID:36032469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9382466/
Abstract

BACKGROUND

The cystine-cystine chemokine receptor 5 (CCR5) is the primary HIV co-receptor involved in the viral entry process into human cells. The 32 bp deletion variant within the CCR5 gene (CCR5-Δ32) plays a very important role in viral recognition and progression of AIDS.

OBJECTIVE

The current study was aimed at evaluating the CCR5-Δ32 gene variation frequency in Nigerian and Zimbabwean populations residing in Northern Cyprus.

METHODS

A total number of 211 subjects (103 Nigerians and 108 Zimbabweans) were analyzed. Nigerian population was further analyzed with respect to the three major ethnicities: Igbo, Hausa, and Yoruba. Polymerase Chain Reaction was used to determine the CCR5-Δ32 gene variant status.

RESULTS

All studied subjects from both sampling groups were homozygous for the CCR5 wild type gene (CCR5-wt), meaning neither heterozygous nor homozygous genotypes of CCR5-Δ32 gene variant were observed.

CONCLUSION

This study observed the absence of CCR5-Δ32 deletion gene in the Nigeria and Zimbabwean populations living in Northern Cyprus. These populations lack the genetic advantage over HIV infection and may also show a rapid progression towards AIDS. Additionally, these populations could impact the local gene frequency as these two populations interact more and more.

摘要

背景

半胱氨酸-半胱氨酸趋化因子受体 5(CCR5)是 HIV 共受体的主要成分,参与病毒进入人体细胞的过程。CCR5 基因内的 32 个碱基对缺失变体(CCR5-Δ32)在病毒识别和艾滋病进展中起着非常重要的作用。

目的

本研究旨在评估居住在北塞浦路斯的尼日利亚和津巴布韦人群中 CCR5-Δ32 基因变异的频率。

方法

共分析了 211 名受试者(103 名尼日利亚人和 108 名津巴布韦人)。进一步分析了尼日利亚人群的三个主要族群:伊博族、豪萨族和约鲁巴族。聚合酶链反应用于确定 CCR5-Δ32 基因变异的状态。

结果

来自两个抽样组的所有研究对象均为 CCR5 野生型基因(CCR5-wt)的纯合子,这意味着未观察到 CCR5-Δ32 基因变异的杂合子或纯合子基因型。

结论

本研究观察到居住在北塞浦路斯的尼日利亚和津巴布韦人群中缺乏 CCR5-Δ32 缺失基因。这些人群缺乏对 HIV 感染的遗传优势,也可能迅速发展为艾滋病。此外,这些人群可能会影响当地的基因频率,因为这两个群体之间的互动越来越多。

相似文献

1
CCR5-Δ32 gene variant frequency in the Nigerian and Zimbabwean populations living in North Cyprus.在北塞浦路斯生活的尼日利亚和津巴布韦人群中 CCR5-Δ32 基因变异频率。
Afr Health Sci. 2022 Mar;22(1):361-366. doi: 10.4314/ahs.v22i1.44.
2
CCR5-Δ32 gene variant frequency in the Turkish Cypriot population.土族塞浦路斯人群中CCR5-Δ32基因变体频率
Braz J Microbiol. 2020 Dec;51(4):1711-1717. doi: 10.1007/s42770-020-00352-8. Epub 2020 Jul 31.
3
Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria.尼日利亚南部卡拉巴尔大学教学医院接受治疗的HIV感染者的半胱氨酸-半胱氨酸趋化因子受体5(CCR5)情况
BMC Infect Dis. 2020 Jan 3;20(1):5. doi: 10.1186/s12879-019-4737-1.
4
Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.巴西南部人群中健康献血者、HIV-1暴露血清阴性者及HIV-1血清阳性者体内1型人类免疫缺陷病毒(HIV-1)中CCR5-Δ32缺失的频率
Int J Mol Med. 2008 Nov;22(5):669-75.
5
Relationship between CCR5 heterozygosity and HIV-1 reservoir size in adolescents and young adults with perinatally acquired HIV-1 infection.围生期感染 HIV-1 的青少年和年轻成人中 CCR5 杂合性与 HIV-1 储存库大小的关系。
Clin Microbiol Infect. 2017 May;23(5):318-324. doi: 10.1016/j.cmi.2016.12.020. Epub 2016 Dec 29.
6
CC chemokine receptor 5 Δ32 polymorphism: association analysis and allele distribution among cutaneous leishmaniasis patients from Pakistan.C-C趋化因子受体5 Δ32多态性:巴基斯坦皮肤利什曼病患者的关联分析及等位基因分布
J Cutan Pathol. 2016 Jul;43(7):564-70. doi: 10.1111/cup.12712. Epub 2016 Apr 6.
7
More about the Viking hypothesis of origin of the delta32 mutation in the CCR5 gene conferring resistance to HIV-1 infection.关于CCR5基因中赋予对HIV-1感染抗性的delta32突变起源的维京假说的更多内容。
Infect Genet Evol. 2003 Nov;3(4):293-5. doi: 10.1016/j.meegid.2003.07.001.
8
Frequency of the CCR5-delta32 allele in Brazilian populations: A systematic literature review and meta-analysis.巴西人群中CCR5-Δ32等位基因的频率:系统文献综述与荟萃分析。
Infect Genet Evol. 2016 Sep;43:101-7. doi: 10.1016/j.meegid.2016.05.024. Epub 2016 May 18.
9
Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.埃及人和叙利亚人中HIV耐药CCR5-Delta32等位基因的分布情况。
Mutat Res. 2007 Mar 1;616(1-2):175-80. doi: 10.1016/j.mrfmmm.2006.11.024. Epub 2006 Dec 12.
10
Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.丙型肝炎患者中具有HIV保护作用的CC趋化因子受体5-Δ32/Δ32基因型的频率增加。
Gastroenterology. 2002 Jun;122(7):1721-8. doi: 10.1053/gast.2002.33660.

引用本文的文献

1
Sexual reproductive health, NCDs and infectious diseases.性生殖健康、非传染性疾病和传染病。
Afr Health Sci. 2022 Mar;22(1):i-v. doi: 10.4314/ahs.v22i1.1.

本文引用的文献

1
CCR5-Δ32 gene variant frequency in the Turkish Cypriot population.土族塞浦路斯人群中CCR5-Δ32基因变体频率
Braz J Microbiol. 2020 Dec;51(4):1711-1717. doi: 10.1007/s42770-020-00352-8. Epub 2020 Jul 31.
2
A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.新冠病毒患者样本与人感觉神经元的药物相互作用组揭示了神经源性肺功能障碍的潜在驱动因素。
Brain Behav Immun. 2020 Oct;89:559-568. doi: 10.1016/j.bbi.2020.05.078. Epub 2020 Jun 1.
3
Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria.尼日利亚南部卡拉巴尔大学教学医院接受治疗的HIV感染者的半胱氨酸-半胱氨酸趋化因子受体5(CCR5)情况
BMC Infect Dis. 2020 Jan 3;20(1):5. doi: 10.1186/s12879-019-4737-1.
4
Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers.基于对来自3个德国骨髓捐赠者登记处(DKMS)国家中心的130万人样本进行的新一代测序,87个国家的基因变体CCR5-Δ32的频率。
Hum Immunol. 2017 Nov;78(11-12):710-717. doi: 10.1016/j.humimm.2017.10.001. Epub 2017 Oct 5.
5
Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.通过 CRISPR/Cas9 同时敲除 CD4+ T 细胞中的 CXCR4 和 CCR5 基因可抵抗 X4 和 R5 嗜性的人类免疫缺陷病毒 1 型感染。
Hum Gene Ther. 2018 Jan;29(1):51-67. doi: 10.1089/hum.2017.032. Epub 2017 Jun 9.
6
The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1.CCR5 拮抗剂马拉维若单独或与 PKC 激动剂波莱霉素 1 联合使用,可逆转体外 HIV-1 潜伏期。
Sci Rep. 2017 May 24;7(1):2385. doi: 10.1038/s41598-017-02634-y.
7
CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.用于治疗HIV及预防病毒逃逸的CCR5靶向细胞疗法。
Viruses. 2015 Jul 27;7(8):4186-203. doi: 10.3390/v7082816.
8
The impact of host genetic variation on infection with HIV-1.宿主基因变异对HIV-1感染的影响。
Nat Immunol. 2015 Jun;16(6):577-83. doi: 10.1038/ni.3147.
9
CCR5 genotypes and progression to HIV disease in perinatally infected children.围产期感染儿童的CCR5基因型与HIV疾病进展
Braz J Infect Dis. 2007 Apr;11(2):196-8. doi: 10.1590/s1413-86702007000200004.
10
Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.埃及人和叙利亚人中HIV耐药CCR5-Delta32等位基因的分布情况。
Mutat Res. 2007 Mar 1;616(1-2):175-80. doi: 10.1016/j.mrfmmm.2006.11.024. Epub 2006 Dec 12.